Fundraising Fox
Haiyan Jiang
InvestorScientific Advisory Group Member at Pathway to Cures
Find your path to Haiyan
Sign up to see every warm intro you have to Haiyan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Haiyan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Jiang is co-founder and Chief Scientific Officer at PointLoma BioSciences with a track record in drug development, cell and gene therapy, and genome editing. She contributed to therapies at Editas Medicine, Biogen, and Bayer and holds a PhD from the University of Wisconsin-Madison.
Colleagues at Pathway to Cures
Frequently asked questions
- Who is Haiyan Jiang?
- Jiang is co-founder and Chief Scientific Officer at PointLoma BioSciences with a track record in drug development, cell and gene therapy, and genome editing. She contributed to therapies at Editas Medicine, Biogen, and Bayer and holds a PhD from the University of Wisconsin-Madison.
- Where does Haiyan Jiang work?
- Haiyan Jiang is Scientific Advisory Group Member at Pathway to Cures.
About this profile. Compiled from public sources — Pathway to Cures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights